[Conformational properties of biologically active melanostatin analogs]. 1990

Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia

On the basis of the two-dimensional 1H NMR studies the conformation of melanocyte inhibiting hormone (HCl.Pro-Leu-Gly-NH2, MIF) and its five analogues with p-substituted phenylalanine has been determined. Structure-antidepressant activity relationship (examined by the Porsolt test) of MIF and its analogues has been estimated by means of the multivariate statistical analysis, the vicinal spin coupling constants, which determine phi and chi dihedral angles of the second amino acid and phi and dihedral angle of glycine, being selected as structural parameters. It is shown that a biologically active conformation (10-membered beta-turn II) is realized for the considered peptides.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009074 Melanocyte-Stimulating Hormones Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS. MSH,Melanocyte Stimulating Hormone,Melanocyte-Stimulating Hormone,Melanophore Stimulating Hormone,Melanotropin,MSH (Melanocyte-Stimulating Hormones),Melanophore-Stimulating Hormone,Hormone, Melanocyte Stimulating,Hormone, Melanocyte-Stimulating,Hormone, Melanophore Stimulating,Melanocyte Stimulating Hormones,Stimulating Hormone, Melanocyte,Stimulating Hormone, Melanophore
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations

Related Publications

Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
February 1982, International journal of peptide and protein research,
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
June 2005, Chemistry & biology,
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
January 1990, Annals of the New York Academy of Sciences,
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
March 1994, Biochemistry,
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
April 1969, Psychopharmacology bulletin,
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
January 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
January 1991, The Journal of antibiotics,
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
February 1999, The journal of peptide research : official journal of the American Peptide Society,
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
December 2008, Neuropharmacology,
Iu E Shapiro, and V Ia Gorbatiuk, and V M Kabanov, and A A Mazurov, and S A Andronati, and B A Lobasiuk, and N Ia Golovenko, and M G Rokachinskaia
July 1997, Nature biotechnology,
Copied contents to your clipboard!